Tag Archives: in vitro diagnostics

New FDA Guidances for March 2013

FDA released several interesting new guidances last month, including several regarding communications with the FDA. Types of Communication During the Review of Medical Device Submissions is in accordance with the MDUFA III goals and includes descriptions of acceptance review communications, substantive … Continue reading

Posted in FDA, Industry News | Tagged , , , , , | Comments Off on New FDA Guidances for March 2013

FDA’s New Guidances for November 2012

Several new guidance documents were released by FDA in November 2012, covering a wide range of subjects.  The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems Highly Multiplexed Microbiological/Medical Countermeasure In Vitro … Continue reading

Posted in Clinical Trials, FDA, Regulatory Strategy | Tagged , , , , , , , , , , | Comments Off on FDA’s New Guidances for November 2012

New FDA Guidances Released in March 2012

Here’s a list of the notable guidances released by FDA in March 2012, compiled by Cato Research Regulatory Scientist Cathy Anderson. Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications Direct-to-Consumer Television Advertisements … Continue reading

Posted in FDA, Industry News | Tagged , , , , , , , , , | Comments Off on New FDA Guidances Released in March 2012

New FDA Guidances – December 2011/January 2012

Here’s a list of the notable guidances released by FDA in December 2011 and January 2012, compiled by Cato Research Regulatory Scientist Cathy Anderson. December 2011 FDA Portable Document Format (PDF) Specifications (Updated) (More info on this guidance can be … Continue reading

Posted in FDA | Tagged , , , , , , , , , , , , , , | Comments Off on New FDA Guidances – December 2011/January 2012

New FDA Guidances Released in July 2011

Here’s a list of the guidances released by FDA in July 2011, compiled by Cato Research Regulatory Scientist Cathy Anderson. 510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device In Vitro Companion Diagnostic … Continue reading

Posted in FDA | Tagged , , , , | Comments Off on New FDA Guidances Released in July 2011